Hi Sean Davis-
Thanks for letting us know how you are doing!!! Just wanted to post this about high dose fish oil having deleterious effects on cf....might want to take it easy on high doses!!
take care.
mandy
J Cyst Fibros. 2007 Jan 24; [Epub ahead of print]
> Links
> Fatty acids platelets and oxidative markers
> following
> intravenous n-3 fatty acids administration in cystic
> fibrosis: An open pilot observational study.
>
> Durieu I, Vericel E, Guichardant D, Roth H, Steghens
> JP, Drai J, Nove Josserand R, Fontaine E, Lagarde M,
> Bellon G.
> Department of Internal Medicine and Cystic Fibrosis
> Adult Center, University Claude Bernard Lyon 1,
> Centre
> Hospitalier Lyon-Sud, 69495 Pierre-Benite cedex,
> France.
> BACKGROUND: An imbalance in the ratio of arachidonic
> acid and docosahexaenoic acid (DHA) was found in
> cystic fibrosis (CF) affected tissues and was
> suggested to promote inflammation. Several studies
> have shown that the long chain n-3 fatty acids
> reduced
> inflammatory activity while others have highlighted
> prooxidant activity of DHA at high concentrations.
> The
> aim of our study was to evaluate the effects of an
> intravenous fish-oil emulsion enriched with n-3 FA
> in
> patients with CF on plasma and platelet FA
> composition
> and peroxidation markers. METHODS: 13 patients with
> CF
> received one IV emulsion per week of 2 mL/kg
> fish-oil
> n-3 emulsion for 12 weeks. RESULTS: There was a
> significant increase in 20:5 n-3 and 22:6 n-3
> platelet
> FA composition, no variation in 20:4 n-6, a decrease
> in n-9. There was no variation in plasma FA
> composition. Specific urinary markers of lipid
> peroxidation derived from n-3 and n-6 showed a very
> high level before infusion compared with usual
> values
> in healthy subjects which was not affected by
> treatment. A significant weight loss and a decrease
> in
> reduced glutathione were observed in adult patients.
> CONCLUSIONS: The intravenous administration of n-3
> FA
> in CF patients induced a significant modification in
> platelet FA composition but no modification of
> oxidative markers.<b> However, the weight loss and the
> decreased level in reduced glutathione observed in
> adult patients may suggest a potential deleterious
> activity for some patients.</b> Further studies are
> necessary to determine the optimal dose and route
> for
> long chain FA administration required to reach a
> potential beneficial effect.
>